ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Tohru Obata, Satoru Mori, Yuka Suzuki, Takuto Kashiwagi, Etsuko Tokunaga, Norio Shibata, Motohiro Tanaka
Photodynamictherapy (PDT) using a photo sensitizing agent and several light sources has been shown to have nonspecific and noninvasive effects on superficial cancers. Phthalocyanine (Pc) derivatives as novel photosensitizers, trifluoroethoxy-coatedzinc Pcconj…
Dina A. Salem, Dina R. Ibrahim, Ahmed Ezzat, Azza M. Adel
Background: Comparing the efficacy and safety of gemcitabine at a fixed-dose rate (FDR) infusion (10 mg/m 2 /min) with the standard dose rate infusion in patients with locally advanced and metastatic non-small squamous cell carcinoma (NSCLC). Methods: The stu…
Stanislaw R. Burzynski, Gregory S. Burzynski, Sheldon Brookman
Diffuse intrinsic pontine glioma (DIPG) is the most common type of brainstem glioma and one of the most deadly brain tumors. DIPG in young adult patients is a rare disease for which treatment options are limited. Radiation therapy remains the standard-of-care…
Ekkasit Tharavichitkul, Sukon Prasitwattanaseree, Cholthicha Thipmate, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan, Razvan M. Galalae, Imjai Chitapanarux
Purpose: To report the retrospective study of using intravaginal brachytherapy as adjuvant monotherapy for endometrial cancer. Materials and Methods: From 2001-2009, 47 patients who received completely surgical staging for endometrial carcinoma and were desig…
Yasser Bayoumi, Aida Radwan
Background and Purpose: The relapsed low grade non-Hodgkin’s lymphoma (LG-NHL) is currently incurable disease and the optimal treatment regimen has not determined yet. Low dose total body irradiation (LTBI) provides an alternative mechanism of action against…
Tarek Debs, Isabella Reccia, Imad El-Hajj, Ziad El-Rassi
Cholangiocarcinoma is an uncommon malignancy that increases with age. Cholangiocarcinoma has been linked to inflammatory bowel disease, and a relationship between inflammatory bowel disease, anti-tumour necrosis factor alpha antibody (Infliximab) and cholangi…
Javier Gallego Plazas, Elena Asensio, Juan C. Navalon, Inmaculada Lozano, Jose M. Navarro, Guillermo Ricote, Montse Olcina, Almudena Cotes, Henry M. Ore, Alejandra Magdaleno, Maria C. Ors, Maria J. Escudero, Miguel A. Morcillo
Background: Colorectal cancer surgery in extreme elderly population ( 3 80 years) is a growing problem and a subject in question. Experiences and results in this scenario are limited. Methods: Medical records of patients 3 80 years old hospitalized in General…
A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein
Background: Dose-modified (dm) CODOX-M/IVAC is commonly used for Burkitt lymphoma (BL) and B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma (DLBCL) and BL (BCL-U; previously Burkitt-like lymphoma-BLL). Methods:…
Lorenzo Bruno, Lucia Barni, Sabrina Pacciani, Gaia Masini, Lorenzo Tofani, Federica Tofani, Filippo Melli, Antonio Taddei, Manuela Andonova Miloeva, Luca Boni, Giancarlo Freschi, Paolo Bechi
Background and Aims : The complication rate after surgery for gastric cancer varies according to the particular definition of morbidity, so it’s necessary to report them using a standardized method, the Clavien-Dindo system. The purpose of this study was to p…
Lorenzo Bruno, Lucia Barni, Gabriella Nesi, Sabrina Pacciani, Gaia Masini, Filippo Melli, Gherardo Maltinti, Tiku Zalla, Lorenzo Dioscoridi, Antonio Taddei, Giancarlo Freschi, Paolo Bechi
Although the prognosis of early gastric cancer (EGC) is considered to be satisfactory, some patients experience tumor relapse after curative surgery. Both pathogenesis and risk factors of recurrence remain unclear. We describe a case report of a 49-year-old m…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).